Annual report [Section 13 and 15(d), not S-K Item 405]

SETTLEMENT LIABILITY (Details Narrative)

v3.25.1
SETTLEMENT LIABILITY (Details Narrative) - USD ($)
$ in Thousands
Nov. 12, 2021
Dec. 31, 2024
Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]      
Long-Term Debt   $ 18,963
REGENXBIO [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Settlement liabilities, current $ 30,000    
Loss contingency settlement agreement terms (1) $20.0 million paid in November 2021 after execution of the Settlement Agreement, (2) $5.0 million on the first anniversary of the effective date of the Settlement Agreement (paid in November 2022), and (3) $5.0 million upon the earlier of (i) the third anniversary of the effective date of the Settlement Agreement or (ii) the closing of a Strategic Transaction, as defined in the Settlement Agreement (paid in November 2024).    
Debt Instrument, Interest Rate, Stated Percentage   9.60%  
Long-Term Debt     $ 4,600